nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—CXCR1—melanoma	0.521	0.718	CbGaD
Ketoprofen—CXCL8—melanoma	0.131	0.181	CbGaD
Ketoprofen—ALB—Vemurafenib—melanoma	0.0423	0.514	CbGbCtD
Ketoprofen—SLC22A7—Docetaxel—melanoma	0.0401	0.487	CbGbCtD
Ketoprofen—PTGS2—melanoma	0.0383	0.0529	CbGaD
Ketoprofen—ALB—melanoma	0.0342	0.0471	CbGaD
Ketoprofen—SLC22A8—optic choroid—melanoma	0.000824	0.183	CbGeAlD
Ketoprofen—PTGS2—leg—melanoma	0.000414	0.092	CbGeAlD
Ketoprofen—CXCR1—lymph node—melanoma	0.000397	0.0883	CbGeAlD
Ketoprofen—PTGS2—hindlimb—melanoma	0.00037	0.0822	CbGeAlD
Ketoprofen—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000333	0.00451	CcSEcCtD
Ketoprofen—Myocardial infarction—Bleomycin—melanoma	0.000331	0.00449	CcSEcCtD
Ketoprofen—Stomatitis—Bleomycin—melanoma	0.000329	0.00446	CcSEcCtD
Ketoprofen—Colitis—Docetaxel—melanoma	0.000325	0.00441	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000324	0.00439	CcSEcCtD
Ketoprofen—Haematuria—Bleomycin—melanoma	0.000322	0.00437	CcSEcCtD
Ketoprofen—PTGS2—appendage—melanoma	0.000318	0.0705	CbGeAlD
Ketoprofen—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000312	0.00423	CcSEcCtD
Ketoprofen—Decreased appetite—Vemurafenib—melanoma	0.000309	0.00419	CcSEcCtD
Ketoprofen—Stomatitis—Dactinomycin—melanoma	0.000307	0.00416	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Vemurafenib—melanoma	0.000307	0.00416	CcSEcCtD
Ketoprofen—Fatigue—Vemurafenib—melanoma	0.000306	0.00416	CcSEcCtD
Ketoprofen—Constipation—Vemurafenib—melanoma	0.000304	0.00412	CcSEcCtD
Ketoprofen—Erectile dysfunction—Temozolomide—melanoma	0.000294	0.00399	CcSEcCtD
Ketoprofen—Agranulocytosis—Dactinomycin—melanoma	0.000294	0.00399	CcSEcCtD
Ketoprofen—Sepsis—Docetaxel—melanoma	0.000294	0.00398	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Temozolomide—melanoma	0.000291	0.00395	CcSEcCtD
Ketoprofen—Weight increased—Temozolomide—melanoma	0.000291	0.00394	CcSEcCtD
Ketoprofen—Renal failure—Carmustine—melanoma	0.00029	0.00393	CcSEcCtD
Ketoprofen—Weight decreased—Temozolomide—melanoma	0.000289	0.00392	CcSEcCtD
Ketoprofen—Stomatitis—Carmustine—melanoma	0.000287	0.0039	CcSEcCtD
Ketoprofen—Hepatitis—Dactinomycin—melanoma	0.000283	0.00383	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000282	0.00383	CcSEcCtD
Ketoprofen—Flushing—Bleomycin—melanoma	0.000281	0.00382	CcSEcCtD
Ketoprofen—Pharyngitis—Dactinomycin—melanoma	0.00028	0.00381	CcSEcCtD
Ketoprofen—Stomatitis—Temozolomide—melanoma	0.000277	0.00377	CcSEcCtD
Ketoprofen—Deafness—Docetaxel—melanoma	0.000275	0.00373	CcSEcCtD
Ketoprofen—Chills—Bleomycin—melanoma	0.000272	0.00369	CcSEcCtD
Ketoprofen—Cardiac failure congestive—Docetaxel—melanoma	0.000271	0.00368	CcSEcCtD
Ketoprofen—Alopecia—Bleomycin—melanoma	0.000268	0.00363	CcSEcCtD
Ketoprofen—Erythema multiforme—Dactinomycin—melanoma	0.000267	0.00363	CcSEcCtD
Ketoprofen—PTGS2—skin epidermis—melanoma	0.000264	0.0587	CbGeAlD
Ketoprofen—Erythema—Bleomycin—melanoma	0.000264	0.00358	CcSEcCtD
Ketoprofen—Hallucination—Carmustine—melanoma	0.000263	0.00357	CcSEcCtD
Ketoprofen—Flushing—Dactinomycin—melanoma	0.000262	0.00356	CcSEcCtD
Ketoprofen—Hypersensitivity—Vemurafenib—melanoma	0.000262	0.00355	CcSEcCtD
Ketoprofen—Visual disturbance—Docetaxel—melanoma	0.000259	0.00352	CcSEcCtD
Ketoprofen—Renal impairment—Docetaxel—melanoma	0.000258	0.0035	CcSEcCtD
Ketoprofen—Dermatitis bullous—Docetaxel—melanoma	0.000257	0.00349	CcSEcCtD
Ketoprofen—Hepatitis—Temozolomide—melanoma	0.000256	0.00347	CcSEcCtD
Ketoprofen—Asthenia—Vemurafenib—melanoma	0.000255	0.00346	CcSEcCtD
Ketoprofen—Visual impairment—Carmustine—melanoma	0.000255	0.00346	CcSEcCtD
Ketoprofen—Hallucination—Temozolomide—melanoma	0.000254	0.00345	CcSEcCtD
Ketoprofen—Pharyngitis—Temozolomide—melanoma	0.000254	0.00344	CcSEcCtD
Ketoprofen—Chills—Dactinomycin—melanoma	0.000253	0.00344	CcSEcCtD
Ketoprofen—Cardiac failure—Docetaxel—melanoma	0.000252	0.00342	CcSEcCtD
Ketoprofen—Pruritus—Vemurafenib—melanoma	0.000251	0.00341	CcSEcCtD
Ketoprofen—Alopecia—Dactinomycin—melanoma	0.00025	0.00339	CcSEcCtD
Ketoprofen—Hyponatraemia—Docetaxel—melanoma	0.000247	0.00335	CcSEcCtD
Ketoprofen—Visual impairment—Temozolomide—melanoma	0.000246	0.00334	CcSEcCtD
Ketoprofen—Erythema—Dactinomycin—melanoma	0.000246	0.00334	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000246	0.00333	CcSEcCtD
Ketoprofen—Flushing—Carmustine—melanoma	0.000245	0.00333	CcSEcCtD
Ketoprofen—Ill-defined disorder—Bleomycin—melanoma	0.000245	0.00332	CcSEcCtD
Ketoprofen—Anaemia—Bleomycin—melanoma	0.000244	0.00331	CcSEcCtD
Ketoprofen—Diarrhoea—Vemurafenib—melanoma	0.000243	0.0033	CcSEcCtD
Ketoprofen—Migraine—Docetaxel—melanoma	0.000242	0.00328	CcSEcCtD
Ketoprofen—Erythema multiforme—Temozolomide—melanoma	0.000242	0.00328	CcSEcCtD
Ketoprofen—Tinnitus—Temozolomide—melanoma	0.000238	0.00323	CcSEcCtD
Ketoprofen—Malaise—Bleomycin—melanoma	0.000238	0.00323	CcSEcCtD
Ketoprofen—Flushing—Temozolomide—melanoma	0.000237	0.00322	CcSEcCtD
Ketoprofen—Arrhythmia—Carmustine—melanoma	0.000236	0.00321	CcSEcCtD
Ketoprofen—Dizziness—Vemurafenib—melanoma	0.000235	0.00319	CcSEcCtD
Ketoprofen—Alopecia—Carmustine—melanoma	0.000234	0.00317	CcSEcCtD
Ketoprofen—Erythema—Carmustine—melanoma	0.00023	0.00312	CcSEcCtD
Ketoprofen—Chills—Temozolomide—melanoma	0.000229	0.00311	CcSEcCtD
Ketoprofen—Ill-defined disorder—Dactinomycin—melanoma	0.000228	0.0031	CcSEcCtD
Ketoprofen—Anaemia—Dactinomycin—melanoma	0.000227	0.00308	CcSEcCtD
Ketoprofen—Vomiting—Vemurafenib—melanoma	0.000226	0.00306	CcSEcCtD
Ketoprofen—Alopecia—Temozolomide—melanoma	0.000226	0.00306	CcSEcCtD
Ketoprofen—Myalgia—Bleomycin—melanoma	0.000224	0.00305	CcSEcCtD
Ketoprofen—Abdominal pain upper—Docetaxel—melanoma	0.000224	0.00304	CcSEcCtD
Ketoprofen—Rash—Vemurafenib—melanoma	0.000224	0.00304	CcSEcCtD
Ketoprofen—Dermatitis—Vemurafenib—melanoma	0.000224	0.00304	CcSEcCtD
Ketoprofen—Headache—Vemurafenib—melanoma	0.000223	0.00302	CcSEcCtD
Ketoprofen—Erythema—Temozolomide—melanoma	0.000222	0.00302	CcSEcCtD
Ketoprofen—Discomfort—Bleomycin—melanoma	0.000222	0.00301	CcSEcCtD
Ketoprofen—Malaise—Dactinomycin—melanoma	0.000222	0.00301	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000221	0.003	CcSEcCtD
Ketoprofen—Carprofen—PTGS2—melanoma	0.000219	0.0803	CrCbGaD
Ketoprofen—Ketorolac—PTGS2—melanoma	0.000219	0.0803	CrCbGaD
Ketoprofen—Dysgeusia—Temozolomide—melanoma	0.000218	0.00296	CcSEcCtD
Ketoprofen—Confusional state—Bleomycin—melanoma	0.000217	0.00294	CcSEcCtD
Ketoprofen—Anaphylactic shock—Bleomycin—melanoma	0.000215	0.00292	CcSEcCtD
Ketoprofen—Oedema—Bleomycin—melanoma	0.000215	0.00292	CcSEcCtD
Ketoprofen—Infection—Bleomycin—melanoma	0.000214	0.0029	CcSEcCtD
Ketoprofen—Anaemia—Carmustine—melanoma	0.000213	0.00289	CcSEcCtD
Ketoprofen—Nausea—Vemurafenib—melanoma	0.000211	0.00286	CcSEcCtD
Ketoprofen—Thrombocytopenia—Bleomycin—melanoma	0.000211	0.00286	CcSEcCtD
Ketoprofen—Bromfenac—PTGS2—melanoma	0.00021	0.077	CrCbGaD
Ketoprofen—Myalgia—Dactinomycin—melanoma	0.000209	0.00284	CcSEcCtD
Ketoprofen—Bronchospasm—Docetaxel—melanoma	0.000209	0.00283	CcSEcCtD
Ketoprofen—Discomfort—Dactinomycin—melanoma	0.000207	0.00281	CcSEcCtD
Ketoprofen—Ill-defined disorder—Temozolomide—melanoma	0.000206	0.0028	CcSEcCtD
Ketoprofen—Anaemia—Temozolomide—melanoma	0.000206	0.00279	CcSEcCtD
Ketoprofen—Anorexia—Bleomycin—melanoma	0.000205	0.00278	CcSEcCtD
Ketoprofen—Angioedema—Temozolomide—melanoma	0.000203	0.00276	CcSEcCtD
Ketoprofen—Oedema—Dactinomycin—melanoma	0.000201	0.00272	CcSEcCtD
Ketoprofen—Malaise—Temozolomide—melanoma	0.000201	0.00272	CcSEcCtD
Ketoprofen—PTGS1—endothelium—melanoma	0.000201	0.0445	CbGeAlD
Ketoprofen—Vertigo—Temozolomide—melanoma	0.0002	0.00271	CcSEcCtD
Ketoprofen—Convulsion—Carmustine—melanoma	0.000199	0.00271	CcSEcCtD
Ketoprofen—Infection—Dactinomycin—melanoma	0.000199	0.00271	CcSEcCtD
Ketoprofen—Hypertension—Carmustine—melanoma	0.000199	0.0027	CcSEcCtD
Ketoprofen—Palpitations—Temozolomide—melanoma	0.000197	0.00267	CcSEcCtD
Ketoprofen—Thrombocytopenia—Dactinomycin—melanoma	0.000197	0.00267	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Bleomycin—melanoma	0.000196	0.00266	CcSEcCtD
Ketoprofen—Myalgia—Carmustine—melanoma	0.000196	0.00266	CcSEcCtD
Ketoprofen—Anxiety—Carmustine—melanoma	0.000195	0.00265	CcSEcCtD
Ketoprofen—Paraesthesia—Bleomycin—melanoma	0.000193	0.00262	CcSEcCtD
Ketoprofen—Weight increased—Docetaxel—melanoma	0.000193	0.00262	CcSEcCtD
Ketoprofen—Convulsion—Temozolomide—melanoma	0.000193	0.00262	CcSEcCtD
Ketoprofen—Weight decreased—Docetaxel—melanoma	0.000192	0.00261	CcSEcCtD
Ketoprofen—Hypertension—Temozolomide—melanoma	0.000192	0.00261	CcSEcCtD
Ketoprofen—Dyspnoea—Bleomycin—melanoma	0.000192	0.0026	CcSEcCtD
Ketoprofen—PTGS2—endothelium—melanoma	0.000192	0.0426	CbGeAlD
Ketoprofen—Anorexia—Dactinomycin—melanoma	0.000191	0.0026	CcSEcCtD
Ketoprofen—Confusional state—Carmustine—melanoma	0.000189	0.00257	CcSEcCtD
Ketoprofen—Myalgia—Temozolomide—melanoma	0.000189	0.00257	CcSEcCtD
Ketoprofen—Anxiety—Temozolomide—melanoma	0.000189	0.00256	CcSEcCtD
Ketoprofen—Oedema—Carmustine—melanoma	0.000188	0.00255	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000188	0.00255	CcSEcCtD
Ketoprofen—Discomfort—Temozolomide—melanoma	0.000187	0.00254	CcSEcCtD
Ketoprofen—Decreased appetite—Bleomycin—melanoma	0.000187	0.00254	CcSEcCtD
Ketoprofen—Infection—Carmustine—melanoma	0.000187	0.00253	CcSEcCtD
Ketoprofen—Acute coronary syndrome—Docetaxel—melanoma	0.000187	0.00253	CcSEcCtD
Ketoprofen—Renal failure—Docetaxel—melanoma	0.000186	0.00253	CcSEcCtD
Ketoprofen—Myocardial infarction—Docetaxel—melanoma	0.000186	0.00252	CcSEcCtD
Ketoprofen—Dry mouth—Temozolomide—melanoma	0.000185	0.00251	CcSEcCtD
Ketoprofen—PTGS1—blood vessel—melanoma	0.000185	0.0411	CbGeAlD
Ketoprofen—Jaundice—Docetaxel—melanoma	0.000185	0.0025	CcSEcCtD
Ketoprofen—Stomatitis—Docetaxel—melanoma	0.000185	0.0025	CcSEcCtD
Ketoprofen—Conjunctivitis—Docetaxel—melanoma	0.000184	0.0025	CcSEcCtD
Ketoprofen—Thrombocytopenia—Carmustine—melanoma	0.000184	0.0025	CcSEcCtD
Ketoprofen—Tachycardia—Carmustine—melanoma	0.000183	0.00249	CcSEcCtD
Ketoprofen—Confusional state—Temozolomide—melanoma	0.000183	0.00248	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000183	0.00248	CcSEcCtD
Ketoprofen—Anaphylactic shock—Temozolomide—melanoma	0.000182	0.00246	CcSEcCtD
Ketoprofen—Oedema—Temozolomide—melanoma	0.000182	0.00246	CcSEcCtD
Ketoprofen—Infection—Temozolomide—melanoma	0.00018	0.00245	CcSEcCtD
Ketoprofen—Anorexia—Carmustine—melanoma	0.000179	0.00243	CcSEcCtD
Ketoprofen—Epistaxis—Docetaxel—melanoma	0.000179	0.00242	CcSEcCtD
Ketoprofen—Tiaprofenic acid—PTGS2—melanoma	0.000179	0.0655	CrCbGaD
Ketoprofen—Thrombocytopenia—Temozolomide—melanoma	0.000178	0.00241	CcSEcCtD
Ketoprofen—Feeling abnormal—Bleomycin—melanoma	0.000177	0.00241	CcSEcCtD
Ketoprofen—PTGS2—blood vessel—melanoma	0.000177	0.0393	CbGeAlD
Ketoprofen—Agranulocytosis—Docetaxel—melanoma	0.000177	0.0024	CcSEcCtD
Ketoprofen—Hyperhidrosis—Temozolomide—melanoma	0.000175	0.00238	CcSEcCtD
Ketoprofen—Decreased appetite—Dactinomycin—melanoma	0.000174	0.00237	CcSEcCtD
Ketoprofen—Fatigue—Dactinomycin—melanoma	0.000173	0.00235	CcSEcCtD
Ketoprofen—Anorexia—Temozolomide—melanoma	0.000173	0.00235	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Carmustine—melanoma	0.000171	0.00232	CcSEcCtD
Ketoprofen—Urticaria—Bleomycin—melanoma	0.000171	0.00232	CcSEcCtD
Ketoprofen—Rhinitis—Docetaxel—melanoma	0.00017	0.00231	CcSEcCtD
Ketoprofen—Hepatitis—Docetaxel—melanoma	0.00017	0.00231	CcSEcCtD
Ketoprofen—Insomnia—Carmustine—melanoma	0.00017	0.00231	CcSEcCtD
Ketoprofen—Nepafenac—PTGS2—melanoma	0.00017	0.0623	CrCbGaD
Ketoprofen—Paraesthesia—Carmustine—melanoma	0.000169	0.00229	CcSEcCtD
Ketoprofen—Pharyngitis—Docetaxel—melanoma	0.000169	0.00229	CcSEcCtD
Ketoprofen—Dyspnoea—Carmustine—melanoma	0.000167	0.00227	CcSEcCtD
Ketoprofen—Somnolence—Carmustine—melanoma	0.000167	0.00227	CcSEcCtD
Ketoprofen—Magnesium salicylate—PTGS2—melanoma	0.000166	0.0609	CrCbGaD
Ketoprofen—SLC22A8—eye—melanoma	0.000166	0.0368	CbGeAlD
Ketoprofen—Feeling abnormal—Dactinomycin—melanoma	0.000165	0.00224	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Temozolomide—melanoma	0.000165	0.00224	CcSEcCtD
Ketoprofen—Insomnia—Temozolomide—melanoma	0.000164	0.00223	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Dactinomycin—melanoma	0.000164	0.00223	CcSEcCtD
Ketoprofen—Visual impairment—Docetaxel—melanoma	0.000164	0.00222	CcSEcCtD
Ketoprofen—Decreased appetite—Carmustine—melanoma	0.000163	0.00222	CcSEcCtD
Ketoprofen—Paraesthesia—Temozolomide—melanoma	0.000163	0.00221	CcSEcCtD
Ketoprofen—Fenbufen—PTGS2—melanoma	0.000162	0.0596	CrCbGaD
Ketoprofen—Gastrointestinal disorder—Carmustine—melanoma	0.000162	0.0022	CcSEcCtD
Ketoprofen—Dyspnoea—Temozolomide—melanoma	0.000162	0.0022	CcSEcCtD
Ketoprofen—Somnolence—Temozolomide—melanoma	0.000161	0.00219	CcSEcCtD
Ketoprofen—Erythema multiforme—Docetaxel—melanoma	0.000161	0.00218	CcSEcCtD
Ketoprofen—Constipation—Carmustine—melanoma	0.000161	0.00218	CcSEcCtD
Ketoprofen—Dyspepsia—Temozolomide—melanoma	0.00016	0.00217	CcSEcCtD
Ketoprofen—Abdominal pain—Dactinomycin—melanoma	0.000159	0.00215	CcSEcCtD
Ketoprofen—Hypersensitivity—Bleomycin—melanoma	0.000159	0.00215	CcSEcCtD
Ketoprofen—Decreased appetite—Temozolomide—melanoma	0.000158	0.00214	CcSEcCtD
Ketoprofen—Flushing—Docetaxel—melanoma	0.000158	0.00214	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Temozolomide—melanoma	0.000157	0.00213	CcSEcCtD
Ketoprofen—Fatigue—Temozolomide—melanoma	0.000157	0.00212	CcSEcCtD
Ketoprofen—Constipation—Temozolomide—melanoma	0.000155	0.00211	CcSEcCtD
Ketoprofen—Feeling abnormal—Carmustine—melanoma	0.000155	0.0021	CcSEcCtD
Ketoprofen—Asthenia—Bleomycin—melanoma	0.000154	0.0021	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Carmustine—melanoma	0.000154	0.00208	CcSEcCtD
Ketoprofen—Chills—Docetaxel—melanoma	0.000152	0.00207	CcSEcCtD
Ketoprofen—Pruritus—Bleomycin—melanoma	0.000152	0.00207	CcSEcCtD
Ketoprofen—Arrhythmia—Docetaxel—melanoma	0.000152	0.00206	CcSEcCtD
Ketoprofen—Alopecia—Docetaxel—melanoma	0.00015	0.00204	CcSEcCtD
Ketoprofen—Feeling abnormal—Temozolomide—melanoma	0.00015	0.00203	CcSEcCtD
Ketoprofen—Abdominal pain—Carmustine—melanoma	0.000148	0.00202	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Temozolomide—melanoma	0.000148	0.00201	CcSEcCtD
Ketoprofen—Erythema—Docetaxel—melanoma	0.000148	0.00201	CcSEcCtD
Ketoprofen—Magnesium salicylate—ALB—melanoma	0.000148	0.0542	CrCbGaD
Ketoprofen—Hypersensitivity—Dactinomycin—melanoma	0.000148	0.00201	CcSEcCtD
Ketoprofen—Dysgeusia—Docetaxel—melanoma	0.000145	0.00197	CcSEcCtD
Ketoprofen—Urticaria—Temozolomide—melanoma	0.000144	0.00196	CcSEcCtD
Ketoprofen—Asthenia—Dactinomycin—melanoma	0.000144	0.00195	CcSEcCtD
Ketoprofen—Abdominal pain—Temozolomide—melanoma	0.000144	0.00195	CcSEcCtD
Ketoprofen—Salsalate—PTGS2—melanoma	0.000141	0.0518	CrCbGaD
Ketoprofen—CXCL8—lymph node—melanoma	0.000141	0.0313	CbGeAlD
Ketoprofen—Hypersensitivity—Carmustine—melanoma	0.000138	0.00188	CcSEcCtD
Ketoprofen—Diarrhoea—Dactinomycin—melanoma	0.000137	0.00186	CcSEcCtD
Ketoprofen—Vomiting—Bleomycin—melanoma	0.000137	0.00186	CcSEcCtD
Ketoprofen—Anaemia—Docetaxel—melanoma	0.000137	0.00186	CcSEcCtD
Ketoprofen—Rash—Bleomycin—melanoma	0.000136	0.00184	CcSEcCtD
Ketoprofen—Dermatitis—Bleomycin—melanoma	0.000136	0.00184	CcSEcCtD
Ketoprofen—Mebendazole—ABCB1—melanoma	0.000135	0.0496	CrCbGaD
Ketoprofen—Suprofen—PTGS2—melanoma	0.000135	0.0496	CrCbGaD
Ketoprofen—Asthenia—Carmustine—melanoma	0.000135	0.00183	CcSEcCtD
Ketoprofen—Hypersensitivity—Temozolomide—melanoma	0.000134	0.00182	CcSEcCtD
Ketoprofen—Palpitations—Docetaxel—melanoma	0.000131	0.00177	CcSEcCtD
Ketoprofen—Asthenia—Temozolomide—melanoma	0.00013	0.00177	CcSEcCtD
Ketoprofen—Diarrhoea—Carmustine—melanoma	0.000129	0.00174	CcSEcCtD
Ketoprofen—Pruritus—Temozolomide—melanoma	0.000128	0.00174	CcSEcCtD
Ketoprofen—Convulsion—Docetaxel—melanoma	0.000128	0.00174	CcSEcCtD
Ketoprofen—Nausea—Bleomycin—melanoma	0.000128	0.00173	CcSEcCtD
Ketoprofen—Hypertension—Docetaxel—melanoma	0.000128	0.00173	CcSEcCtD
Ketoprofen—Vomiting—Dactinomycin—melanoma	0.000128	0.00173	CcSEcCtD
Ketoprofen—Rash—Dactinomycin—melanoma	0.000127	0.00172	CcSEcCtD
Ketoprofen—Myalgia—Docetaxel—melanoma	0.000126	0.00171	CcSEcCtD
Ketoprofen—Dizziness—Carmustine—melanoma	0.000124	0.00169	CcSEcCtD
Ketoprofen—Diarrhoea—Temozolomide—melanoma	0.000124	0.00169	CcSEcCtD
Ketoprofen—Dry mouth—Docetaxel—melanoma	0.000123	0.00167	CcSEcCtD
Ketoprofen—Confusional state—Docetaxel—melanoma	0.000122	0.00165	CcSEcCtD
Ketoprofen—Anaphylactic shock—Docetaxel—melanoma	0.000121	0.00164	CcSEcCtD
Ketoprofen—Oedema—Docetaxel—melanoma	0.000121	0.00164	CcSEcCtD
Ketoprofen—Dizziness—Temozolomide—melanoma	0.00012	0.00163	CcSEcCtD
Ketoprofen—Infection—Docetaxel—melanoma	0.00012	0.00163	CcSEcCtD
Ketoprofen—Vomiting—Carmustine—melanoma	0.000119	0.00162	CcSEcCtD
Ketoprofen—Nausea—Dactinomycin—melanoma	0.000119	0.00162	CcSEcCtD
Ketoprofen—Shock—Docetaxel—melanoma	0.000119	0.00161	CcSEcCtD
Ketoprofen—Rash—Carmustine—melanoma	0.000118	0.00161	CcSEcCtD
Ketoprofen—Dermatitis—Carmustine—melanoma	0.000118	0.00161	CcSEcCtD
Ketoprofen—Thrombocytopenia—Docetaxel—melanoma	0.000118	0.0016	CcSEcCtD
Ketoprofen—Tachycardia—Docetaxel—melanoma	0.000118	0.0016	CcSEcCtD
Ketoprofen—Headache—Carmustine—melanoma	0.000118	0.0016	CcSEcCtD
Ketoprofen—Fenoprofen—PTGS2—melanoma	0.000117	0.0428	CrCbGaD
Ketoprofen—Vomiting—Temozolomide—melanoma	0.000115	0.00157	CcSEcCtD
Ketoprofen—Anorexia—Docetaxel—melanoma	0.000115	0.00156	CcSEcCtD
Ketoprofen—Rash—Temozolomide—melanoma	0.000114	0.00155	CcSEcCtD
Ketoprofen—Dermatitis—Temozolomide—melanoma	0.000114	0.00155	CcSEcCtD
Ketoprofen—Headache—Temozolomide—melanoma	0.000114	0.00154	CcSEcCtD
Ketoprofen—Nausea—Carmustine—melanoma	0.000112	0.00151	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Docetaxel—melanoma	0.00011	0.00149	CcSEcCtD
Ketoprofen—Insomnia—Docetaxel—melanoma	0.000109	0.00148	CcSEcCtD
Ketoprofen—Paraesthesia—Docetaxel—melanoma	0.000108	0.00147	CcSEcCtD
Ketoprofen—Mefenamic acid—PTGS2—melanoma	0.000108	0.0397	CrCbGaD
Ketoprofen—Nausea—Temozolomide—melanoma	0.000108	0.00146	CcSEcCtD
Ketoprofen—Dyspnoea—Docetaxel—melanoma	0.000108	0.00146	CcSEcCtD
Ketoprofen—Somnolence—Docetaxel—melanoma	0.000107	0.00146	CcSEcCtD
Ketoprofen—Dyspepsia—Docetaxel—melanoma	0.000106	0.00144	CcSEcCtD
Ketoprofen—Naproxen—PTGS2—melanoma	0.000106	0.0389	CrCbGaD
Ketoprofen—Decreased appetite—Docetaxel—melanoma	0.000105	0.00142	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Docetaxel—melanoma	0.000104	0.00141	CcSEcCtD
Ketoprofen—Fatigue—Docetaxel—melanoma	0.000104	0.00141	CcSEcCtD
Ketoprofen—Fenoprofen—ALB—melanoma	0.000104	0.0381	CrCbGaD
Ketoprofen—Constipation—Docetaxel—melanoma	0.000103	0.0014	CcSEcCtD
Ketoprofen—Feeling abnormal—Docetaxel—melanoma	9.95e-05	0.00135	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Docetaxel—melanoma	9.87e-05	0.00134	CcSEcCtD
Ketoprofen—SLCO1A2—head—melanoma	9.86e-05	0.0219	CbGeAlD
Ketoprofen—Abdominal pain—Docetaxel—melanoma	9.54e-05	0.0013	CcSEcCtD
Ketoprofen—ABCC4—head—melanoma	9.49e-05	0.0211	CbGeAlD
Ketoprofen—Naproxen—ALB—melanoma	9.46e-05	0.0347	CrCbGaD
Ketoprofen—SLC22A8—head—melanoma	9.41e-05	0.0209	CbGeAlD
Ketoprofen—Phenprocoumon—ALB—melanoma	8.96e-05	0.0329	CrCbGaD
Ketoprofen—Hypersensitivity—Docetaxel—melanoma	8.89e-05	0.00121	CcSEcCtD
Ketoprofen—Asthenia—Docetaxel—melanoma	8.66e-05	0.00118	CcSEcCtD
Ketoprofen—PTGS1—skin of body—melanoma	8.56e-05	0.019	CbGeAlD
Ketoprofen—Pruritus—Docetaxel—melanoma	8.54e-05	0.00116	CcSEcCtD
Ketoprofen—Diarrhoea—Docetaxel—melanoma	8.26e-05	0.00112	CcSEcCtD
Ketoprofen—PTGS2—skin of body—melanoma	8.18e-05	0.0182	CbGeAlD
Ketoprofen—Dizziness—Docetaxel—melanoma	7.98e-05	0.00108	CcSEcCtD
Ketoprofen—Warfarin—ALB—melanoma	7.95e-05	0.0291	CrCbGaD
Ketoprofen—PTGS1—mammalian vulva—melanoma	7.81e-05	0.0173	CbGeAlD
Ketoprofen—Vomiting—Docetaxel—melanoma	7.68e-05	0.00104	CcSEcCtD
Ketoprofen—Rash—Docetaxel—melanoma	7.61e-05	0.00103	CcSEcCtD
Ketoprofen—Flurbiprofen—PTGS2—melanoma	7.61e-05	0.0279	CrCbGaD
Ketoprofen—Dermatitis—Docetaxel—melanoma	7.6e-05	0.00103	CcSEcCtD
Ketoprofen—Headache—Docetaxel—melanoma	7.56e-05	0.00103	CcSEcCtD
Ketoprofen—Nausea—Docetaxel—melanoma	7.17e-05	0.000973	CcSEcCtD
Ketoprofen—ALB—lymph node—melanoma	6.86e-05	0.0152	CbGeAlD
Ketoprofen—Flurbiprofen—ALB—melanoma	6.78e-05	0.0249	CrCbGaD
Ketoprofen—ABCC4—lymph node—melanoma	6.64e-05	0.0148	CbGeAlD
Ketoprofen—PTGS1—head—melanoma	5.59e-05	0.0124	CbGeAlD
Ketoprofen—PTGS2—head—melanoma	5.34e-05	0.0119	CbGeAlD
Ketoprofen—PTGS1—lymph node—melanoma	3.91e-05	0.00869	CbGeAlD
Ketoprofen—PTGS2—lymph node—melanoma	3.74e-05	0.0083	CbGeAlD
Ketoprofen—CXCL8—Signaling Pathways—KDR—melanoma	6.68e-06	5.96e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NOS2—melanoma	6.64e-06	5.93e-05	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—PIK3CA—melanoma	6.64e-06	5.93e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GPAM—melanoma	6.63e-06	5.92e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.62e-06	5.91e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP17A1—melanoma	6.45e-06	5.76e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CG—melanoma	6.43e-06	5.74e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FN1—melanoma	6.43e-06	5.74e-05	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—melanoma	6.43e-06	5.74e-05	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PIK3CA—melanoma	6.37e-06	5.69e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.36e-06	5.68e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—EGF—melanoma	6.36e-06	5.68e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NOTCH1—melanoma	6.29e-06	5.62e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	6.28e-06	5.61e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT3—melanoma	6.24e-06	5.57e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—VCAN—melanoma	6.22e-06	5.56e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—VCAN—melanoma	6.19e-06	5.52e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CD80—melanoma	6.17e-06	5.5e-05	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—melanoma	6.16e-06	5.5e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KIT—melanoma	6.15e-06	5.49e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—APC—melanoma	6.15e-06	5.49e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CG—melanoma	6.15e-06	5.49e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—NRAS—melanoma	6.15e-06	5.49e-05	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HRAS—melanoma	6.14e-06	5.49e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GNA11—melanoma	6.09e-06	5.44e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGF—melanoma	6.08e-06	5.43e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.04e-06	5.39e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—FASN—melanoma	5.96e-06	5.32e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—MAPK3—melanoma	5.89e-06	5.26e-05	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HRAS—melanoma	5.89e-06	5.26e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.89e-06	5.26e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IGF1—melanoma	5.89e-06	5.26e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC5A5—melanoma	5.87e-06	5.24e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.86e-06	5.23e-05	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	5.83e-06	5.21e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—BRAF—melanoma	5.79e-06	5.16e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.69e-06	5.08e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CD44—melanoma	5.67e-06	5.06e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GNAQ—melanoma	5.67e-06	5.06e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CD—melanoma	5.66e-06	5.05e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.65e-06	5.05e-05	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL6—melanoma	5.64e-06	5.04e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PLA2G6—melanoma	5.64e-06	5.03e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IGF1—melanoma	5.64e-06	5.03e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ABCB1—melanoma	5.63e-06	5.03e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—MAPK1—melanoma	5.61e-06	5.01e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EGFR—melanoma	5.61e-06	5.01e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.6e-06	5e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.55e-06	4.95e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERBB4—melanoma	5.51e-06	4.92e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN2B—melanoma	5.47e-06	4.88e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MAP2K1—melanoma	5.45e-06	4.86e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP1B1—melanoma	5.43e-06	4.85e-05	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—AKT1—melanoma	5.43e-06	4.84e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CD—melanoma	5.41e-06	4.83e-05	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—PIK3CA—melanoma	5.36e-06	4.78e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CG—melanoma	5.34e-06	4.77e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—KRAS—melanoma	5.3e-06	4.73e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CD86—melanoma	5.29e-06	4.72e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP17A1—melanoma	5.25e-06	4.69e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP17A1—melanoma	5.22e-06	4.66e-05	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AKT1—melanoma	5.2e-06	4.65e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PRKCA—melanoma	5.19e-06	4.63e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FGF2—melanoma	5.18e-06	4.62e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.18e-06	4.62e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PPARG—melanoma	5.15e-06	4.6e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.15e-06	4.6e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ERCC2—melanoma	5.14e-06	4.59e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FGF1—melanoma	5.13e-06	4.58e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	5.11e-06	4.56e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—VCAN—melanoma	5.07e-06	4.52e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PDGFRA—melanoma	4.97e-06	4.43e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GNA11—melanoma	4.96e-06	4.43e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GNA11—melanoma	4.93e-06	4.4e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CB—melanoma	4.93e-06	4.4e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PRKCA—melanoma	4.92e-06	4.39e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERCC2—melanoma	4.87e-06	4.35e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PIK3CA—melanoma	4.87e-06	4.34e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—FASN—melanoma	4.85e-06	4.33e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MDM2—melanoma	4.85e-06	4.33e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—FASN—melanoma	4.82e-06	4.31e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MAP2K2—melanoma	4.81e-06	4.29e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.79e-06	4.28e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.79e-06	4.28e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ERBB2—melanoma	4.78e-06	4.27e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC5A5—melanoma	4.77e-06	4.26e-05	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	4.76e-06	4.25e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC5A5—melanoma	4.75e-06	4.24e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CB—melanoma	4.72e-06	4.21e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CD—melanoma	4.69e-06	4.19e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ALB—melanoma	4.63e-06	4.14e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.63e-06	4.13e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GNAQ—melanoma	4.61e-06	4.12e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CD44—melanoma	4.61e-06	4.12e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GNAQ—melanoma	4.58e-06	4.09e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CD44—melanoma	4.58e-06	4.09e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TERT—melanoma	4.57e-06	4.08e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HLA-A—melanoma	4.57e-06	4.08e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—RAC1—melanoma	4.56e-06	4.07e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IL2—melanoma	4.53e-06	4.04e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.51e-06	4.03e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HRAS—melanoma	4.5e-06	4.02e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.49e-06	4.01e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ABCB1—melanoma	4.47e-06	3.99e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.47e-06	3.99e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.45e-06	3.97e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN1B—melanoma	4.43e-06	3.95e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP1B1—melanoma	4.42e-06	3.95e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP1B1—melanoma	4.39e-06	3.92e-05	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AKT1—melanoma	4.38e-06	3.91e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HIF1A—melanoma	4.37e-06	3.9e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CASP3—melanoma	4.34e-06	3.87e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL2—melanoma	4.33e-06	3.87e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL6—melanoma	4.31e-06	3.85e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP17A1—melanoma	4.27e-06	3.82e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.26e-06	3.8e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCND1—melanoma	4.22e-06	3.77e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.21e-06	3.76e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CTNNB1—melanoma	4.18e-06	3.73e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	4.16e-06	3.71e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PRKCA—melanoma	4.12e-06	3.68e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—melanoma	4.1e-06	3.66e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CB—melanoma	4.09e-06	3.65e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN1A—melanoma	4.08e-06	3.65e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ERCC2—melanoma	4.08e-06	3.64e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTEN—melanoma	4.08e-06	3.64e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CG—melanoma	4.06e-06	3.63e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NFKB1—melanoma	4.06e-06	3.62e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—melanoma	4.05e-06	3.62e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GNA11—melanoma	4.04e-06	3.6e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AKT1—melanoma	3.98e-06	3.55e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOS2—melanoma	3.98e-06	3.55e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—FASN—melanoma	3.95e-06	3.53e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOTCH1—melanoma	3.94e-06	3.51e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PPARG—melanoma	3.92e-06	3.5e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.9e-06	3.48e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC5A5—melanoma	3.88e-06	3.47e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.88e-06	3.46e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CD80—melanoma	3.86e-06	3.44e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KIT—melanoma	3.85e-06	3.44e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—APC—melanoma	3.85e-06	3.44e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—melanoma	3.85e-06	3.44e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGF—melanoma	3.81e-06	3.4e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NRAS—melanoma	3.8e-06	3.39e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CD44—melanoma	3.75e-06	3.35e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GNAQ—melanoma	3.75e-06	3.35e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—melanoma	3.68e-06	3.29e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.67e-06	3.28e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—STAT3—melanoma	3.64e-06	3.25e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.64e-06	3.25e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—MAPK3—melanoma	3.64e-06	3.25e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ABCB1—melanoma	3.64e-06	3.25e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NRAS—melanoma	3.64e-06	3.25e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—BRAF—melanoma	3.62e-06	3.23e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ABCB1—melanoma	3.62e-06	3.23e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP1B1—melanoma	3.6e-06	3.21e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CD—melanoma	3.57e-06	3.19e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTEN—melanoma	3.54e-06	3.16e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ALB—melanoma	3.52e-06	3.15e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MAPK3—melanoma	3.48e-06	3.11e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—MAPK1—melanoma	3.46e-06	3.09e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MAP2K1—melanoma	3.41e-06	3.04e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MYC—melanoma	3.39e-06	3.02e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CD—melanoma	3.38e-06	3.02e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.38e-06	3.02e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PRKCA—melanoma	3.35e-06	2.99e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PRKCA—melanoma	3.33e-06	2.97e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ERCC2—melanoma	3.32e-06	2.97e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MAPK1—melanoma	3.31e-06	2.96e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGFR—melanoma	3.31e-06	2.96e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ERCC2—melanoma	3.3e-06	2.95e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KRAS—melanoma	3.27e-06	2.92e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FGF2—melanoma	3.24e-06	2.89e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CG—melanoma	3.22e-06	2.88e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.17e-06	2.83e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KRAS—melanoma	3.13e-06	2.79e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CB—melanoma	3.11e-06	2.78e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PPARG—melanoma	3.11e-06	2.78e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—melanoma	3.08e-06	2.75e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MDM2—melanoma	3.03e-06	2.71e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CA—melanoma	3.01e-06	2.68e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERBB2—melanoma	2.99e-06	2.67e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ABCB1—melanoma	2.96e-06	2.64e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CB—melanoma	2.95e-06	2.63e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CD4—melanoma	2.94e-06	2.63e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—melanoma	2.91e-06	2.6e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CA—melanoma	2.87e-06	2.57e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CD—melanoma	2.83e-06	2.53e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ALB—melanoma	2.8e-06	2.5e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—melanoma	2.78e-06	2.48e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HRAS—melanoma	2.78e-06	2.48e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN1B—melanoma	2.77e-06	2.47e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.75e-06	2.46e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.74e-06	2.44e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PRKCA—melanoma	2.73e-06	2.43e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ERCC2—melanoma	2.7e-06	2.41e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTEN—melanoma	2.69e-06	2.4e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HRAS—melanoma	2.66e-06	2.37e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CG—melanoma	2.62e-06	2.34e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CTNNB1—melanoma	2.62e-06	2.34e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CG—melanoma	2.61e-06	2.33e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN1A—melanoma	2.56e-06	2.28e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PTEN—melanoma	2.55e-06	2.28e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL6—melanoma	2.55e-06	2.27e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPARG—melanoma	2.53e-06	2.26e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPARG—melanoma	2.52e-06	2.25e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CA—melanoma	2.49e-06	2.23e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CB—melanoma	2.47e-06	2.21e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—AKT1—melanoma	2.46e-06	2.19e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKT1—melanoma	2.35e-06	2.1e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CD—melanoma	2.31e-06	2.06e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CD—melanoma	2.29e-06	2.05e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—STAT3—melanoma	2.28e-06	2.04e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ALB—melanoma	2.28e-06	2.03e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NRAS—melanoma	2.27e-06	2.03e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.24e-06	2e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MAPK3—melanoma	2.18e-06	1.94e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CG—melanoma	2.14e-06	1.91e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PTEN—melanoma	2.13e-06	1.91e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MYC—melanoma	2.12e-06	1.89e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MAPK1—melanoma	2.07e-06	1.85e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGFR—melanoma	2.07e-06	1.85e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPARG—melanoma	2.06e-06	1.84e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKT1—melanoma	2.04e-06	1.82e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CB—melanoma	2.01e-06	1.79e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CB—melanoma	2e-06	1.78e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—melanoma	1.99e-06	1.78e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—melanoma	1.98e-06	1.77e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KRAS—melanoma	1.96e-06	1.75e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CA—melanoma	1.9e-06	1.69e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CD—melanoma	1.88e-06	1.68e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALB—melanoma	1.85e-06	1.65e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CA—melanoma	1.8e-06	1.61e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTEN—melanoma	1.74e-06	1.55e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTEN—melanoma	1.73e-06	1.54e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HRAS—melanoma	1.66e-06	1.49e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CB—melanoma	1.64e-06	1.46e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—melanoma	1.62e-06	1.45e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IL6—melanoma	1.59e-06	1.42e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKT1—melanoma	1.55e-06	1.38e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CA—melanoma	1.51e-06	1.34e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT1—melanoma	1.47e-06	1.31e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTEN—melanoma	1.41e-06	1.26e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKT1—melanoma	1.23e-06	1.1e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CA—melanoma	1.23e-06	1.09e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CA—melanoma	1.22e-06	1.09e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKT1—melanoma	1e-06	8.94e-06	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CA—melanoma	9.97e-07	8.9e-06	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKT1—melanoma	9.95e-07	8.89e-06	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKT1—melanoma	8.15e-07	7.27e-06	CbGpPWpGaD
